Clear Harbor Asset Management, LLC Context Therapeutics Inc. Transaction History
Clear Harbor Asset Management, LLC
- $1.79 Billion
- Q3 2025
A detailed history of Clear Harbor Asset Management, LLC transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Clear Harbor Asset Management, LLC holds 92,804 shares of CNTX stock, worth $117,861. This represents 0.01% of its overall portfolio holdings.
Number of Shares
92,804
Previous 57,804
60.55%
Holding current value
$117,861
Previous $38,000
136.84%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CNTX
# of Institutions
43Shares Held
75.9MCall Options Held
0Put Options Held
0-
Bio Impact Capital LLC Cambridge, MA14.7MShares$18.7 Million1.9% of portfolio
-
Avidity Partners Management LP Dallas, TX7.48MShares$9.5 Million1.33% of portfolio
-
Nextech Invest Ag7.42MShares$9.42 Million1.37% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$9.42 Million0.17% of portfolio
-
Nextech Invest, Ltd. Zurich, V87.42MShares$9.42 Million0.92% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $20.3M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...